Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis

Zhengyuan Cheng, Xiaojuan Zhang, Pingsheng Chen, Haitao Wang, Kuangjing Wang, Yingzhou Shen · 2023

Read Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis by Zhengyuan Cheng, Xiaojuan Zhang, Pingsheng Chen, Haitao Wang, Kuangjing Wang, Yingzhou Shen (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710214.txt.

Description

Zhengyuan Cheng and co-authors test a drug strategy against liver fibrosis in a 2023 study. Fibrosis is chronic liver damage marked by low oxygen and excess scar matrix. Hepatic stellate cells drive it when activated, so calming them or killing them selectively is a leading strategy.

The team targeted a kinase called Src, which low oxygen switches on in these cells. Blocking the kinase pushed the activated stellate cells into ferroptosis, an iron-linked form of cell death. Fibrosis eased as a result, suggesting a precise way to remove the very cells that build the scar.

Catalog record

CREATORZhengyuan Cheng, Xiaojuan Zhang, Pingsheng Chen, Haitao Wang, Kuangjing Wang, Yingzhou Shen
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10710214

Browse the full library · About the Tower of Babel